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The cardiac myosin phenotype, an important determi-
nant of myocardial contractility, is modified by chronic
increases in hemodynamic load. To quantify the pro-
portion of atrial alpha-myosin heavy chain in various
types of left atrial overload and to assess the possible
relation between this proportion and atrial size, 34 pa-
tients were studied , 4 with Wolff-Parkinson-White syn-
drome, 29 with various types of mitral valvedysfunction
and 1 with an atrial septal defect. Four normal autopsy
hearts were also studied. The proportion of alpha-myosin
heavy chain among total (alpha plus beta) myosin heavy
chains was determined in each atrial sample, using an
enzyme-linked immunosorbent assay. The size of the left
atrium was assessed by one- and two-dimensional echo-
cardiography.
Alpha-myosin heavy chain was the main isoform
present in the normal atria (85.5 ± 9% of total myosin
heavy chains). Patients with pure tight mitral stenosis
(n = 9), mitral stenosis plus mild regurgitation (n = 8)
Hypertrophy is characteristic of hearts subjected to a chronic
increase in hemodynamic work . The adaptive nature of this
process at the level of the cardiac pump is well established,
because the resulting increase in ventricular wall thickness
tends to restore normal systolic or diastolic wall stress , or
both (I ). In addition to this quantitative process , qualitati ve
changes in several proteins involved in myocyte contractile
function also occur. In this respect , the isomyosin transition
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and severe mitral regurgitation (n = 8), who had a
higher indexed left atrial transverse diameter than those
with Wolff-Parkinson-White syndrome (33 ± 6, 39 ±
10 and 46 ± 5 versus 19.5 ± 2 mm/m", p < 0.01, p <
0.001 and p < 0.001, respectively), also demonstrated
a much smaller percent of alpha-myosin heavy chain
content (28 ± 20, 23.5 ± 13 and 12 ± 10 versus 58 ±
18%, p < 0.01, P < 0.01 and p < 0.001, respectively).
Significant negative linear correlations were observed
between the percent alpha-myosin heavy chain content
and either the indexed left atrial transverse diameter (r
=0.54, r =0.73, P < 0.001) or the indexed left atrial
area (r2 =0.43, r =0.66, p < 0.001).
These data demonstrate a profound transformation
of myosin phenotype in the chronically overloaded hu-
man left atrium and suggest that isomyosin transitions
are related to the severity or duration, or both, of the
atrial overload, whatever its type.
(J Am Call CardioI1987;9:1024-30)
observed when rat (2-4) and rabbit (5) ventricles are sub-
mitted to a chronic hemodynamic overload is of great func-
tional significance , because myosin . the main protein of the
contractile apparatus , is at least partly responsible for the
degree of contractility of the constituent muscle.
Two types of myosin heavy chain isoform , alpha and
beta, linked to ventricular-type light chains , form pairs giv-
ing rise to alpha-alpha and beta-beta homodimers, which
correspond , respectively, to the V1 and V3 isomyosins with
high and low adenosine triphosphatase (ATPase) activity ,
and to an alpha-beta heterodimer (V2) with intermediate
activity (6). Chronic hemodynamic overload results in a
transition from the alpha to the beta form and thus reduces
myosin ATPase activity (2), which in turn leads to slower
(7,8) but more efficient (9) myocardial contraction . The
ability to develop such an adaptive process is maximal in
the adult rat ventricle, which is essentially composed of
alpha-myosin heavy chain (2-4,6), is intermediate in the
0735-1097 /87/$3 .50
lACC Vol. 9, NO.5
May 1987:1024-30
MERCADIER ET AL.
ALPHA·MYOSIN HEAVY CHAIN AND ATRIALOVERLOAD
1025
rabbit ventricle, which comprises smaller amounts of this
form (5), and is almost zero in the human ventricle, which
contains essentially a beta-myosin heavy chain isoform (10),
Atrial myocardium (which is characterized by higher con-
tractile performance [II], or at least higher contractile re-
serve [12], and higher myosin ATPase activity [13-15] than
the corresponding ventricle) essentially contains alpha-myosin
heavy chain (16-22) linked to atrial-type light chains. A
transition from the atrial to the ventricular light chain pattern
was shown in chronic pressure overload of the human left
atrium (23), Using an immunocytochemical technique, we
(17) and others (24,25) have reported an alpha- to beta-
myosin heavy chain transition in the chronically overloaded
human left atrium, and a rough estimation of alpha- and
beta-myosin heavy chain content showed a relation between
this transition and mean atrial pressure (24). However, im-
munocytochemistry yields only semiquantitative results and
no attention has been paid to the type of atrial overload or
to atrial size, an important factor contributing to atrial fiber
load, which moreover testifies both to the severity and du-
ration of the overload.
We undertook the present study to 1) quantify the true
proportion of alpha-myosin heavy chain present in the nor-
mal and chronically overloaded left atrium, 2) detect specific
alterations in this proportion according to the type of over-
load, and 3) test the possible relation between this proportion
and atrial size.
Methods
Study patients. This study comprised 34 patients, 15
men and 19 women (mean age 45 ± 14 years) operated on
by the same surgeon at our institution between January 1984
and September 1985. Informed consent of the patients had
been obtained. Four patients had Wolff-Parkinson-White
syndrome and underwent section of an accessory pathway
because of life-threatening arrhythmia (Group I). None had
associated cardiovascular disease. The other 30 subjects
were patients whose operation consisted of the repair of a
cardiac lesion that had been causing a hemodynamic over-
load of the left atrium. Patients with severe aortic valve
dysfunction or ischemic heart disease were excluded from
this study. The patients were classified into four subgroups
(Groups 2 to 5) on the basis of their history and on clinical,
echocardiographic, phonomechanographic and surgical
findings, as well as hemodynamic and angiographic data for
the patients who underwent preoperative cardiac catheter-
ization (Table I).
Twenty-five patients (Groups 2 to 4) had a history ot"
longstanding left atrial overload secondary to rheumatic
lesions of the mitral valve. Almost all of them had been
receiving digitalis and diuretic drugs. Group 2 comprised
nine patients with pure tight mitral stenosis, Group 3 eight
patients with tight mitral stenosis plus mild mitral regur-
gitation and Group 4 eight patients with predominant severe
mitral regurgitation. The mitral regurgitation was graded
3 + or 4 + in the six patients in Group 4 who underwent
preoperative left ventricular angiography; the two other pa-
tients in this group were operated on under emergency sit-
uation because of their poor hemodynamic condition, and
surgical and pathologic examination revealed, as it did in
the first six, a totally incompetent and deteriorated mitral
valve. Only Patient 16 (Group 3) and Patient 29 (Group 4)
had associated significant aortic regurgitation (2 +) that re-
sulted in aortic valve replacement.
Group 5 included five patients who could not be classified
in anyone of the previous groups because of their specific
characteristics; three of them had had acute mitral regur-
gitation of recent onset due to chordae tendineae rupture,
one had moderate functional mitral regurgitation (2 + ) sec-
ondary to aortic regurgitation and one had an atrial septal
defect.
In addition, an atrial specimen was excised <12 hours
after death from the left atrium of four autopsy patients
(mean age 46 ± 12 years; death caused by carcinoma in
two, alcoholic cirrhosis in one and stroke in one) free of
known cardiac disease. Pathologic examination revealed the
mitral valve and left atrium to be normal.
Echocardiography. All patients underwent echocardi-
ography during the month before surgery. Echocardiograms
were performed according to the recommendations of the
American Society of Echocardiography (26,27), using a
Roche RT-400 sector scanner with a 3.5 MHz phased array
transducer. Left atrial transverse diameter was measured
from the M-mode echocardiographic scans at end-systole.
Frame by frame analysis of the two-dimensional scans (ap-
ical four chamber view) allowed determination of the max-
imal left atrial area that was estimated by planimetry (28),
using a tablet digitizer and an Apple IIE microcomputer.
To avoid cycle to cycle variations, left atrial transverse
diameter and left atrial area were measured in three cycles
and expressed as the resulting means. To minimize variance
due to body size, data are expressed both as the values
measured and as the values indexed per square meter of
body surface area.
Quantification of atrial alpha-myosin heavy chain. To
avoid variations due to possible regional heterogeneity, the
same surgeon sampled peri-operative and autopsy specimens
in the same left atrial area located in the posterolateral wall,
I em below the interatrial groove, at the time of left atrial
incision. Each sample was placed in crushed ice, frozen in
liquid nitrogen and stored at - 70°C within half an hour of
sampling. The standard isomyosins used in the immuno-
chemical assay came from the ventricles of 3 week old rats,
which contain pure V1 or alpha-alpha isomyosin, and ven-
tricles of hypothyroid rats, which contain pure V3 or beta-
beta isomyosin. Myosins were prepared as described by
Schwartz et al. (29), except that the ammonium sulfate
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Table 1. Clinical Features of the 34 Patients
Patient Age (yr) Atrial PCWP CI LATD* LAA* a-MHC
No. & Sex Rhythm (minHg) (liters/rrr') mm mrn/rrr' ern? cm 2/m2 (%)
Group I: Wolff-Parkinson-White syndrome
I 41M SRiA 30 17 15 8.4 78
2 39M SRiA 35 19 12 6.6 45
3 60F SR/A 34 21 20 12.3 68
4 46F SR/A 32 21 17 II 40
Mean 46.5 19.5 9.6 58
± SD ±9.5 ±2 ±2.6 ± 18
Group 2: Mitral Stenosis
5 42M SR 36 2.1 42 24 23 13.3 63
6 42F SR 9/32 2.7 41 27 24 15.8 28
7 26F SR 24 2.9 41 27 36
8 51F SR 20 1.6 40 30 22 16.4 17
9 30M SR 36 55 33 35 21.2 23
10 49M AF I i/24 2.5 52 35 26 17.6 57
II 58M AF 17 2.2 62 36 34 19.8 15
12 47F AF 16 2.2 62 39 29 18 10
13 64F AF 5 1.6 70 44 7
Mean 45.4 33 17.4 28
± SD ± 12.2 ±6 ±2.6 ±20
Group 3: Mitral Stenosis and Mild Regurgitation
14 33F SR 9/21 2.7 45 25 44
15 55F AF 13 1.8 50 28 27 15 30
16t 62M AF 24 2.4 55 32 27 15.7 17
17 42M AF 55 36 39 25.8 9
18 65F AF 20 70 42 5
19 55M AF 20 2.8 75 46 54 33.3 32
20 58F AF 17 1.7 70 48 39 26.7 25
21 72F AF 29 79 54 44 30.1 26
Mean 55.2 39 24.4 23.5
± SD ± 12.5 ±IO ±7.5 ± 13
Group 4: Severe Mitral Regurgitation
22 47F AF 20 3.6 55 38 5
23 46M AF 25 2.1 72 40 49 26.9 27
24 19F AF 72 45 76 47.5 3
25 24F AF 25 1.8 68 46 36 24.5 9
26 45F AF 16/24 1.9 71 47 34 22.5 12
27 22M AF 19 1.8 68 48 29 20.4 29
28 29F AF 14/19 2.1 78 49 78 49 3
29t 26F AF 30 1.9 72 55 II
Mean 32.2 46 31.8 12
± SD ±11.8 ±5 ± 12.9 ±10
Group 5: Miscellaneous Diagnosis
30 mr, AR 60F SR 12/30 2.1 35 19 90
31 ASD 17M SR 7 2.8 32 19 17 10 70
32 MR (RCT) 45M SR 25 2.8 42 24 77
33 MR (RCT) 51M AF 26 1.8 52 28 25 13.6 62
34 MR (RCT) 58M SR 27 2.5 50 30 15
*Listed as measured and indexed values. tHad associated aortic regurgitation. A = arrhythmias; AF = atriallibrillation; a-MHC = proportion of
alpha-myosin heavy chain among total heavy chains; AR = aortic regurgitation; ASD = atrial septal defect; CI = basal cardiac index; F = female;
LAA = left atrial area; LATD = left atrial transverse diameter; M = male; MR, mr = severe and moderate mitral regurgitation, respectively; PCWP
= mean pulmonary capillary wedge pressure before/after volume loading; RCT = ruptured chordae tendinae; SR = sinus rhythm. Within each group,
patients are listed in order of increasing indexed left atrial transverse diameter.
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fractionation was replaced by a 2 hour centrifugation at
100,000 x g. In each experiment, rat and human myosins
were prepared in parallel. The content of alpha-myosin heavy
chain expressed as percent of the total (alpha and beta)
myosin heavy chains was measured in duplicate by an en-
zyme-linked immunosorbent assay (ELISA) on polystyrene
plates using immunoglobulins raised in guinea pigs against
rat ventricular V I heavy meromyosin. The specificity of
these immunoglobulins for alpha-myosin heavy chain and
the quantitative assay have been described previously (10,30).
The amounts of coating antigen and antiserum dilution were
chosen so as to allow accurate determination of the pro-
portion of alpha-myosin heavy chain, not only when it was
low or intermediate, but also when it was high. A typical
curve is shown in Figure I.
Statistical analysis. Statistical signifi cance was evalu-
ated by one-way analysis of variance, assuming equality of
variance between the groups. Autopsy samples and Group
5 were not included in the analysis because of different
tissue origins and patient heterogeneity, respectively. Group
to group comparison was carried out using Scheffe's test
for multiplecontrasts. Correlation coefficients between per-
cent alpha-myosin heavy chain content and either left atrial
transverse diameter or left atrial area were calculated by the
least square method, using a linear regression equation.
Results are expressed as means ± SO.
Results
Clinical features. Table I lists all data, allowing the
echocardiographic and immunoenzymatic findings to be re-
lated to clinical features for each of the 34 patients studied.
The mean age of patients with severe mitral regurgitation
(Group 4) was slightly smaller than that of the patients in
the first three groups. In those operated on for Wolff-Par-
kinson-White syndrome (Group I) periods of sinus rhythm
alternated with periods of reciprocating tachycardia or of
supraventricular arrhythmia. Five of the nine patients with
mitral stenosis (Group 2) as well as one of the eight with
mitral stenosis plus mild regurgitation (Group 3) had sinus
rhythm. All the other patients in Groups 2 and 3. as well
as all those with severe mitral regurgitation (Group 4), had
permanent atrial fibrillation. Four of the fi ve patients in
Group 5 (miscellaneous group) had sinus rhythm. Basal
mean pulmonary capillary wedge pressure and cardiac index
values were rather scattered (see Discussion). However, as
expected, mean pulmonary capillary wedge pressure mark-
edly increased in the patients who underwent volume load-
ing (250 to 500 ml macromolecular solution) (Table I).
Echocardiographic characteristics. The four groups of
patients (Groups 2 to 5) differed in mean indexed left atrial
transverse diameter (F = 13.35, P < 0.001 ), whereas those
with Wolff-Parkinson-White syndrome (Group I) had a mean
indexed left atrial transverse diameter of 19.5 ± 2 rnm/rrr '
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Figure I. Typical standard curve obtained in the immunoquan-
titative assay of the proportionof alpha-myosin heavy chain. This
proportion in each atrial myosin sample was that of the standard
isomyosin mixture which yieldedan equivalent optical density. ex-
MHC = alpha-myosin heavy chain; a.D. = optical density.
that was within normal limits (1 2 to 22 rnm/rrr' ) (31 ). Pa-
tients with mitral stenosis (Group 2), mitral stenosis plus
mild regurgitation (Group 3) and severe mitral regurgitation
(Group 4) all had a higher mean indexed left atrial transverse
diameter (33 ± 6, 39 ± 10 and 46 ± 5 versus 19.5 ± 2
rnm/m", p < 0.01, P < 0.001and p < 0.00I. respectively).
Mean indexed left atrial transverse diameter for Group 4
patients was higher than that for Group 2 patients (p <
0.00 I) and was at the limit of statistical significance com-
pared with the value for Group 3 patients (p = 0.05) .
Proportions of atrial alpha-myosin heavy chain. Al-
pha-myosin heavy chain was the predominant isoform in
the four normal autopsy atria (85.5 ± 9% of total myosin
heavy chains) (Fig. 2). It was also the major component in
the left atrium of two of the four patients with Wolff-Par-
kinson-White syndrome (Group I), two of the nine patients
with mitral stenosis (Group 2) and four of the five patients
in Group 5. By contrast, alpha-myosin heavy chain was a
minor component in the left atrium of 23 of the 25 patients
operated on for rheumatic mitral valve dysfunction (that is,
seven of nine patients in Group 2 and all patients in Groups
3 and 4). Analysis of variance revealed that the four groups
differed in their mean percent alpha-myosin heavy chain
content (F = 7.69, P < 0.001 ); it was 58 ± 18% in patients
with Wolff-Parkinson-White syndrome (Group I), but de-
creased to 28 ± 20% in patients with mitral stenosis (Group
2), 23.5 ± 13% in those with mitral stenosis plus mild
regurgitation (Group 3) and 12 ± 10% in those with severe
mitral regurgitation (Group 4) (p < 0.01, P < 0.01 and p
< 0.001, respectively, for comparisons with Group I). Al-
though the mean percent alpha-myosin heavy chain content
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Figure 2. Proportion of alpha-myosin heavy chain in the left atrial
autopsy specimen (A, 0), and in the left atrium of patients with
the Wolff-Parkinson-White syndrome (I, 0), pure tight mitral
stenosis (2, !:::,., A), mitral stenosis plus mild regurgitation (3, \j,
T) and severe mitral regurgitation (4, .) and patients with other
types of left atrial overload (5, D, .) (see Table I). Open sym-
bols, Patients who have sinus rhythm; closed symbols, patients
who have atrial fibrillation. Cross bars mean values ± SE.
in patients with mitral stenosis plus mild regurgitation (Group
3) did not significantly differ either from that of patients
with mitral stenosis (Group 2) or severe mitral regurgitation
(Group 4), it was smaller in Group 4 than in Group 2 (p <
0.05).
Relation between atrial alpha-myosin heavy chain and
atrial size. The expected observation of large differences
among the mean indexed left atrial transverse diameter of
the four groups of patients prompted us to look for a relation
between the proportion of alpha-myosin heavy chain and
the size of the left atrium. As the characteristics of the 5
patients in Group 5 did not constitute a reason for excluding
them from such assessment, they were pooled with the other
29 patients. We found a significant negative linear corre-
lation between the percent alpha-myosin heavy chain and
the corresponding indexed left atrial transverse diameter (n
= 34, r = 0.54, r = 0.73, P < 0.001) (Fig. 3). We also
found a less strong but nevertheless significant negative
linear correlation between the percent alpha-myosin heavy
chain and the left atrial area (n = 25, r2 = 0.43, r = 0.66,
P < 0.001).
Among all the patients with left atrial overload resulting
from mitral valve dysfunction, we found a smaller mean
percent alpha-myosin heavy chain in those with atrial fi-
brillation than in those with sinus rhythm (20 ± 17 versus
43 ± 12, P < 0.01). They did not differ in mean age (46.8
± 15.5 versus 43 ± 12, P = NS), but patients with atrial
fibrillation had a larger mean indexed left atrial transverse
diameter than did those with sinus rhythm (42 ± 8 versus
26 ± 5 mm/m", p < 0.001).
Discussion
Effect of chronic mechanical overload on atrial myosin
phenotype. This study demonstrates a drastic decrease in
the proportion of atrial alpha-myosin heavy chain in patients
with various types of chronic dysfunction of the mitral valve
and shows a negative correlation between the percent alpha-
myosin heavy chain content and the degree of atrial dilation,
an index that can be regarded as testifying to the combined
effects of both the severity and the duration of the overload .
Our results are consistent with previous immunocyto-
chemical observations (17,24,32). Because patients with
mitral stenosis have a concomitant increase in the number
of atrial cells labeled with anti-beta-myosin heavy chain
immunoglobulins (17,24,32), it is most likely that the per-
cent beta-myosin heavy chain content increases and the per-
cent alpha-myosin heavy chain content decreases. If atrial
and ventricular beta-myosin heavy chains are assumed to
be identical, which is not yet firmly established, this would
mean that in the human atrium, chronic hemodynamic over-
load induces a transition from an atrial to a ventricular
myosin heavy chain isoform.
Biochemical trigger and possible underlying mecha-
nisms. Little is known about the biochemical triggers re-
sponsible for the alpha- to beta-myosin heavy chain tran-
sition. Alpha- and beta-myosin heavy chains are the products
of two different genes and the transitions observed in rat
and rabbit ventricle with thyroid hormone imbalances occur
at the pretranslational level, the two alpha- and beta-genes
Figure 3. Relation between the indexed left atrial transverse di-
ameter (LATD) and the associated changes in the proportion of
atrial alpha-myosin heavy chain in 34 cases. (r = 0.54, r =
0.73, P < 0.001). Symbols as in Figure 2.
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being regulated in an antithetic fashion (33-35). Preliminary
results (lzumo et al., unpublished observations) indicate that
the mechanism will be the same in the pressure-overloaded
rat ventricle, but it is not yet known if this is true also for
the human atrium.
It was striking to observe here that the proportion of
alpha-myosin heavy chain in the left atrium of patients with
severe chronic mitral regurgitation was lower than that of
patients with mitral stenosis because volume overload is
usually considered to alter myocardial contractility, myosin
ATPase activity and the isomyosin pattern less radically than
pressure overload (3,36). The intergroup differences in the
proportion of alpha-myosin heavy chain (Fig. 2) and the
relations between this proportion and atrial size (Fig. 3) may
be due to the pathophysiologic consequences of mitral ste-
nosis and regurgitation, both of which induce atrial dilation
accompanied by various degrees of muscle hypertrophy.
This increase in atrial size is usually larger with mitral
regurgitation than with mitral stenosis, and larger still when
the two types of valve dysfunction are combined (28,37).
Despite the variable increase in atrial wall thickness, the
great expansion of the left atrium that occurs with long-
standing mitral stenosis and regurgitation will further aug-
ment left atrial wall stress and thus the load of atrial muscle
fibers during the whole cardiac cycle. Therefore, we can
hypothesize that the isomyosin transition we observed in
the overloaded left atrium occurred in response to a chronic
increase in atrial fiber load. We noted indeed that patients
with more recent or less severe atrial overload, or both,
than those with rheumatic mitral valve dysfunction had both
a smaller atrium and higher percent alpha-myosin heavy
chain content (for example, Case 30 to 33).
We did not observe good correlations between the atrial
percent alpha-myosin heavy chain content and either the
basal mean pulmonary capillary wedge pressure or cardiac
index (Table 1), whereas Tsuchimochi et al. (24) observed
a significant negative linear correlation between atrial pres-
sure and a score based on both the number of myocytes
labeled with anti-alpha-myosin heavy chain immunoglob-
ulins and the intensity of the immunolabeling. In fact, both
pulmonary capillary wedge pressure and cardiac index are
instantaneous variables that depend, at least in part, on
ventricular contractile function and compliance, as well as
on blood volume and on the degree of vascular resistance,
that is, on dietary sodium, diuretics, cardiac glycosides and
other therapy, factors that were not homogeneous in our
patients before cardiac catheterization.
Several other factors could have affected the proportion
of alpha-myosin heavy chain. An age-related decrease in
this proportion has been reported in rats (3,6,38), so that
age is most unlikely to have affected our results, because
the patients with severe mitral regurgitation, who had the
smallest mean percent alpha-myosin heavy chain content,
also were the youngest. It is possible that atrial fibrillation
and other arrhythmias playa role in the isomyosin transition.
Indeed, among the patients with mitral valve dysfunction,
we found a smaller mean percent alpha-myosin heavy chain
content for those with atrial fibrillation than for those with
sinus rhythm but it must be noted that the latter had a smaller
left atrium than the former. By contrast, patients with Wolff-
Parkinson-White syndrome who experienced frequent epi-
sodes of severe arrhythmias had an atrium that, although
normal in size, exhibited a smaller percent alpha-myosin
heavy chain content than did the normal autopsy hearts.
Finally, a direct effect of certain medications, such as car-
diac glycosides, calcium antagonists and amiodarone, al-
though unlikely, cannot be totally excluded, especially in
patients with Wolff-Parkinson-White syndrome.
Functional significance and implications. The func-
tional significance of the isomyosin transitions observed in
the overloaded human atrium has not been definitively es-
tablished. In rat and rabbit ventricle these transitions are,
at least in part, responsible for a reduction in the velocity
of muscle shortening (7,8) and they favor the efficiency of
ventricular contraction (9). Very recently, a preliminary
report (39) indicated an alteration in the velocity of muscle
contraction of the overloaded human right atrium that strongly
suggests that the functional significance of isomyosin shifts
are the same in the atria and ventricles.
The observation of a relation between isomyosin tran-
sition and the size of the atrium in various types of atrial
overload indicates that the human atrium has the same po-
tential as the ventricle to regulate the expression of myosin
heavy chain genes in a way that depends on the severity
and duration of the overload whatever its type. The dis-
covery of other isoprotein transitions in the overloaded hu-
man myocardium and the elucidation of their regulatory
mechanisms opens up a new approach to our understanding
of cardiac adaptive growth and of the biochemical mecha-
nisms that govern the transition from compensated hyper-
trophy to cardiac failure. These isoprotein transitions could
also, in specific cases, be used as indicators of the degree
of myocardial adaptation in cardiac diseases.
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A.M. Lornpre, PhD for their constant interest and encouragement in this
work; to J. Acar, MD for valuable advice; to A. Bajolet, MD, J.F. Mon-
sallier, MD, 1. Yalty, MD and to J. Bailly, MD, F. Fraisse, MD, D.
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